22, p<0.0001), pulse pressure (β=0.05, p<0.0001), DM (β=1.33, p=0.04) and ProBNP (per µg/l β=0.18, p=0.0008). AAC and cIMT were associated with incident cardiovascular death independent of DM. DM is associated with increased AAC but not increased cIMT or attenuated FMD in advanced CKD patients.DM is associated with increased AAC but not increased cIMT or attenuated FMD in advanced CKD patients. The high consumption of dates during Ramadan raises the question about its glycemic index (GI) and its effect on the glycemic control in patients with type 2 diabetes (T2DM). We aimed to determine the GI of varieties of meals containing dates in healthy subjects compared to patients with T2DM and the effect of dates on the postprandial glucose excursions using continuous glucose monitoring system (CGMS). Twenty patients with T2DM and twenty healthy subjects matched for age, sex and body weight participated. Testing was applied on separate days (on 3 occasions) with 50g of glucose and 50g equivalent of available carbohydrates from 9 date meals. The GI was calculated as ratios of the incremental areas under the response curves for dates in comparison to glucose. Minimed-530g-diabetes-system-with-enlite was used for continuous glucose monitoring. There was no significant difference between the mean GI of dates between both study groups. However, there was a significant difference according to the time of peak blood glucose among varieties of meals containing dates in T2DM. Studied varieties of dates have low GI. CGMS valued beyond GI calculation to study the postprandial glucose excursions among patients with T2DM.Studied varieties of dates have low GI. CGMS valued beyond GI calculation to study the postprandial glucose excursions among patients with T2DM. This study describes the prevalence and management of uninsured patients with diabetes in free clinics around the Tampa Bay area. A retrospective chart review collected data from uninsured patients who visited nine free clinics from January 2016 to December 2017. The data included sociodemographics, chronic disease diagnoses and treatments, and social history. Statistical analysis including chi-square tests and logistic regression were used to describe patients with diabetes. With a prevalence of 19.41% among 6815 uninsured patients and a mean HbA1c of 7.9% (63mmol/mol), patients with diabetes were more likely to be White, women, obese, unemployed, and have hypertension and depression compared to patients without diabetes. There were no significant differences in sociodemographic variables between those with controlled and uncontrolled diabetes. Among the variables studied by logistic regression, unemployment was found to be a significant predictor of poor glycemic control among men. Diabetes is a challenging chronic disease among the uninsured of Tampa Bay due to its prevalence and suboptimal glycemic control. Obesity and unemployment represent significant challenges that increase the burden of diabetes among the uninsured. Free clinics may benefit from additional resources and intervention programs, with future research assessing their effects on care outcomes.Diabetes is a challenging chronic disease among the uninsured of Tampa Bay due to its prevalence and suboptimal glycemic control. Obesity and unemployment represent significant challenges that increase the burden of diabetes among the uninsured. https://www.selleckchem.com/peptide/jnj-77242113-icotrokinra.html Free clinics may benefit from additional resources and intervention programs, with future research assessing their effects on care outcomes. This systematic review and meta-analysis aims to evaluate the safety and efficacy of the newer glucose lowering treatments on glycemic control, weight, blood pressure and hypoglycemia in patients with T2DM during Ramadan. A literature search was done in PubMed, Embase, and the Cochrane Library. Quality assessment was done using the ROBINS-I and Cochrane tools for risk of bias and analyses were performed using RevMan version 5.3. A total of 20 studies were included in the meta-analysis. Dipeptidyl peptidase-4 inhibitors (DPP-4i) led to a significant reduction in Hb (%) (SMD -0.25) and a non-significant decrease in weight (kg) (SMD -1.06) during Ramadan. Glucagon-like peptide (GLP-1) agonist therapy was associated with a significant decrease in Hb (%) (SMD -0.68) and a non-significant decrease in weight (kg) (SMD -2.57) and systolic blood pressure (SBP) (mmHg) (SMD -3.50) after Ramadan. Sodium-glucose co-transporter 2 inhibitor (SGLT-2i) therapy was associated with a significant decrease in Hb (%) (SMD -0.51) and a non-significant decrease in weight (kg) (SMD -1.41), SBP (SMD -1.10) and diastolic blood pressure (DBP) (mmHg) (SMD -2.08) after Ramadan. This systematic review and meta-analysis shows clinical benefits with the newer glucose lowering medications in patients with T2DM who fast during Ramadan.This systematic review and meta-analysis shows clinical benefits with the newer glucose lowering medications in patients with T2DM who fast during Ramadan. To measure the effect of depression on mortality of individuals newly treated with antidiabetic drugs, accounting for non-persistence to treatment. We conducted a nested case-control study within a cohort of newly treated individuals with diabetes. Using Quebec administrative data, we identified all-cause, diabetes-related, cardiovascular-related and major cardiovascular event deaths during a maximum follow-up of eight years. Each case was matched with up to 10 controls by age, sex, follow-up, and comorbidity index. We used conditional logistic regressions to estimate the effect of depression on mortality, adjusting for non-persistence to antidiabetic drug treatment, and other variables. We retrieved 13,558 deaths, of which 3,652 were related to cardiovascular diseases, 2,112 to major cardiovascular events, and 311 to diabetes. Depression was associated with an increased risk of all-cause and cardiovascular-related deaths, with adjusted odds ratios (ORs) ranging from 1.32 (95% CI 1.21-1.45) to 1.72 (95% CI 1.57-1.88) depending on the model, but not with diabetes-related mortality. Depression is independently associated with all-cause and cardiovascular-related mortality in individuals with type 2 diabetes, even when adjusting for non-persistence to antidiabetic drug treatment. Identifying risk factors for depression and implementing a screening and proper treatment for depression may help reducing mortality.Depression is independently associated with all-cause and cardiovascular-related mortality in individuals with type 2 diabetes, even when adjusting for non-persistence to antidiabetic drug treatment. Identifying risk factors for depression and implementing a screening and proper treatment for depression may help reducing mortality.